In the A549 lung cancer cell line, α-hederin was shown to inhibit c-Myc and HIF-1α by increasing the expression of SIRT6 to inhibit glycolysis and further inhibit the proliferation of A549 cells (113). Here, SIRT6 is linked to lung cancer.